Steven M. Dunn

1.7k citations

25 papers · 923 indexed · h-index 13

Oncology top 5%
Immunology top 5%
Molecular Biology
Radiology, Nuclear Medicine and Imaging top 10%
Genetics

Co-authors: Bent K. Jakobsen Tara Mahon Yangbing Zhao Paul F. Robbins Alan Bennett Zhili Zheng Steven A. Rosenberg Peter Molloy
Topics: Monoclonal and Polyclonal Antibodies Research (10 papers)CAR-T cell therapy research (9 papers)Radiopharmaceutical Chemistry and Applications (5 papers)
Cited by: Immunology Oncology Virology
Journals: Journal of Biological Chemistry Nature Medicine The Journal of Immunology
Partner nations: Switzerland United States United Kingdom

In The Last Decade

Steven M. Dunn

24 papers receiving 904 citations

Peers

Countries citing papers authored by Steven M. Dunn

Since Specialization

Citations

This map shows the geographic impact of Steven M. Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Dunn more than expected).

Fields of papers citing papers by Steven M. Dunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Dunn. The network helps show where Steven M. Dunn may publish in the future.

Co-authorship network of co-authors of Steven M. Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Dunn. A scholar is included among the top collaborators of Steven M. Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Dunn. Steven M. Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phage display enables machine learning discovery of cancer antigen–specific TCRs 2025 ·Science Advances ·Giancarlo Croce,(unknown),(unknown),Sara Bobisse,(unknown),Maiia E. Bragina,Marta A. S. Perez,Justine Michaux,(unknown),Alexandra Michel,(unknown),Julien Schmidt,(unknown),Michal Bassani‐Sternberg,Vincent Zoete,Alexandre Harari,Nathalie Rufer,Michaël Hebeisen,Steven M. Dunn,David Gfeller	2
2	Potent and durable control of mesothelin-expressing tumors by a novel T cell-secreted bi-specific engager 2025 ·Journal for ImmunoTherapy of Cancer ·Paris Kosti,(unknown),(unknown),(unknown),(unknown),(unknown),Melita Irving,George Coukos,Evripidis Lanitis,Steven M. Dunn	0
3	From bench to bedside: 64Cu/177Lu 1C1m-Fc anti TEM-1: mice-to-human dosimetry extrapolations for future theranostic applications 2023 ·EJNMMI Research ·Silvano Gnesin,Nicolas Chouin,Michel Chérel,Steven M. Dunn,Niklaus Schaefer,Alain Faivre-Chauvet,John O. Prior,(unknown)	1
4	A cell-based phenotypic library selection and screening approach for the de novo discovery of novel functional chimeric antigen receptors 2022 ·Scientific Reports ·(unknown),(unknown),Vassilios Atsaves,(unknown),(unknown),Patrick Reichenbach,Melita Irving,George Coukos,Steven M. Dunn	8
5	Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model 2021 ·Pharmaceutics ·(unknown),Alain Faivre-Chauvet,Jacques Barbet,(unknown),Niklaus Schaefer,George Coukos,David Viertl,Steven M. Dunn,Silvano Gnesin,John O. Prior	12
6	Soluble trivalent engagers redirect cytolytic T cell activity toward tumor endothelial marker 1 2021 ·Cell Reports Medicine ·(unknown),(unknown),(unknown),(unknown),Vassilios Atsaves,(unknown),Tatiana V. Petrova,George Coukos,Steven M. Dunn	12
7	177Lu radiolabeling and preclinical theranostic study of 1C1m-Fc: an anti-TEM-1 scFv-Fc fusion protein in soft tissue sarcoma 2020 ·EJNMMI Research ·(unknown),Alain Faivre-Chauvet,(unknown),Silvano Gnesin,Niklaus Schaefer,George Coukos,Steven M. Dunn,David Viertl,John O. Prior	14
8	Biological evaluation of new TEM1 targeting recombinant antibodies for radioimmunotherapy: In vitro, in vivo and in silico studies 2020 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown),Lurdes Gano,Rita Melo,Filipa Mendes,Maria Cristina Oliveira,(unknown),Niklaus Schaefer,David Viertl,(unknown),George Coukos,Steven M. Dunn,John O. Prior,António Paulo	5
9	Rotea: a closed and automated instrument for efficient cell isolation, washing and conentration in cell therapy workflows 2020 ·Cytotherapy ·Carl Dargitz,(unknown),Steven M. Dunn,Xavier de Mollerat du Jeu,Namritha Ravinder	4
10	Integrating SpyCatcher/SpyTag covalent fusion technology into phage display workflows for rapid antibody discovery 2019 ·Scientific Reports ·(unknown),(unknown),(unknown),(unknown),George Coukos,Steven M. Dunn	16
11	Mutagenesis by Phage Display 2015 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Pauline Bonvin,Christopher Power,Amanda E. I. Proudfoot,Steven M. Dunn	1
12	Identification of the Pharmacophore of the CC Chemokine-binding Proteins Evasin-1 and -4 Using Phage Display 2014 ·Journal of Biological Chemistry ·Pauline Bonvin,Steven M. Dunn,François Rousseau,Douglas P. Dyer,Jeffrey P. Shaw,Christopher Power,Tracy M. Handel,Amanda E. I. Proudfoot	23
13	Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer 2014 ·Oncotarget ·Chunsheng Li,Junying Wang,Jia Hu,Yi Feng,Kosei Hasegawa,Xiaohui Peng,Xingmei Duan,Aizhi Zhao,John L. Mikitsh,Vladimir R. Muzykantov,Ann‐Marie Chacko,Daniel A. Pryma,Steven M. Dunn,George Coukos	13
14	High affinity soluble ILT2 receptor: a potent inhibitor of CD8+ T cell activation 2010 ·Protein & Cell ·Ruth Moysey,Yi Li,Samantha Paston,Emma Baston,Malkit Sami,Brian Cameron,(unknown),Penio Todorov,Annelise Vuidepot,Steven M. Dunn,Nicholas J. Pumphrey,Katherine J. Adams,Fang Yuan,(unknown),Deborah H. Sutton,(unknown),Joanna E. Brewer,Rebecca Ashfield,Nikolai M. Lissin,Bent K. Jakobsen	7
15	Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions 2008 ·The Journal of Immunology ·Paul F. Robbins,Yong F. Li,Mona El‐Gamil,Yangbing Zhao,Jennifer A. Wargo,Zhili Zheng,Hui Xu,Richard A. Morgan,Steven A. Feldman,Laura A. Johnson,Alan Bennett,Steven M. Dunn,Tara Mahon,Bent K. Jakobsen,Steven A. Rosenberg	252
16	Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor 2008 ·Nature Medicine ·Angel Varela‐Rohena,Peter Molloy,Steven M. Dunn,Yi Li,Megan M. Suhoski,Richard G. Carroll,(unknown),Tara Mahon,Deborah H. Sutton,Bruno Laugel,Ruth Moysey,Brian Cameron,Annelise Vuidepot,Marco A. Purbhoo,David K. Cole,Rodney E. Phillips,Carl H. June,Bent K. Jakobsen,Andrew K. Sewell,James L. Riley	197
17	T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding 2008 ·Molecular Immunology ·David K. Cole,Steven M. Dunn,Malkit Sami,Jonathan M. Boulter,Bent K. Jakobsen,Andrew K. Sewell	36
18	High-Affinity TCRs Generated by Phage Display Provide CD4+ T Cells with the Ability to Recognize and Kill Tumor Cell Lines 2007 ·The Journal of Immunology ·Yangbing Zhao,Alan Bennett,Zhili Zheng,Qiong J. Wang,Paul F. Robbins,(unknown),Yi Li,Peter Molloy,Steven M. Dunn,Bent K. Jakobsen,Steven A. Rosenberg,Richard A. Morgan	164
19	Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide‐MHC without increasing apparent cross‐reactivity 2006 ·Protein Science ·Steven M. Dunn,P.J. Rizkallah,Emma Baston,Tara Mahon,Brian Cameron,Ruth Moysey,Feng Gao,Malkit Sami,Jonathan M. Boulter,Yi Li,Bent K. Jakobsen	86
20	Crystallization and preliminary diffraction studies of NodL, a rhizobial O‐acetyl‐transferase involved in the host‐specific nodulation of legume roots 1996 ·Protein Science ·Steven M. Dunn,P.C.E. Moody,J. Allan Downie,William V. Shaw	4

About Steven M. Dunn

Steven M. Dunn is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology, having authored 25 papers that have together received 923 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), CAR-T cell therapy research (9 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). The work is most often cited by research in Immunology (605 citations), Oncology (618 citations) and Virology (60 citations). Steven M. Dunn has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Bent K. Jakobsen, Tara Mahon, Yangbing Zhao, Paul F. Robbins, Alan Bennett, Zhili Zheng, Steven A. Rosenberg, Peter Molloy, Ruth Moysey and Yi Li. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact